Natural History Study of Infants and Children With Developmental and Epileptic Encephalopathies
NCT04537832 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 58
Last updated 2023-06-12
Summary
This is a multicenter, prospective, 2-year observational study in infants and children with developmental and epileptic encephalopathies (DEEs). The DEE currently being investigated is SCN1A-positive Dravet Syndrome.
Conditions
Interventions
- OTHER
-
No Intervention
No Intervention
Sponsors & Collaborators
-
Encoded Therapeutics
lead INDUSTRY
Principal Investigators
-
Salvador Rico, M.D., Ph.D · Encoded Therapeutics
Eligibility
- Min Age
- 6 Months
- Max Age
- 60 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-01-18
- Primary Completion
- 2023-03-31
- Completion
- 2023-03-31
Countries
- United States
- Australia
- Spain
- United Kingdom
Study Locations
More Related Trials
-
Expanded Access Use of Stiripentol in Dravet Syndrome or Sodium Channel Mutation Epileptic Encephalopathies
NCT02239276 ·Status: NO_LONGER_AVAILABLE
-
Extension Study to Evaluate How Safe and Tolerable NBI-921352 is as an Adjunctive Therapy for Participants With SCN8A-DEE
NCT05226780 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
European Non-interventional Study on Refractory Epilepsy With Developmental Delay
NCT04398667 ·Status: TERMINATED
-
Cardiac Arrhythmias in Dravet Syndrome
NCT02415686 ·Status: COMPLETED
-
Extended Access Program With Lorcaserin For The Treatment of Dravet Syndrome and Other Refractory Epilepsies
NCT04457687 ·Status: AVAILABLE
-
A Study of Divalproex Sodium in Children With ASD and Epileptiform EEG
NCT01170325 ·Status: WITHDRAWN ·Phase: PHASE2
-
BMB-101 in Absence Epilepsy and DEE
NCT06401538 ·Status: RECRUITING ·Phase: PHASE2
-
Novel Epidermal Recording and Detection of Seizures
NCT02451618 ·Status: TERMINATED
-
Genotype, Phenotype, and Disease Progression of Developmental Epileptic Encephalopathy With Onset Before 2 Years of Age
NCT06278428 ·Status: RECRUITING
-
A Study to Gather Information About Overall Occurrence and New Cases of Dravet and Lennox-Gastaut Syndromes in Children, Teenagers and Adults in Spain
NCT05982717 ·Status: COMPLETED
-
Pathophysiology Based Therapy of Early Onset Epileptic Encephalopathies
NCT02968966 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Clinical Trial of PRAX-222 in Pediatric Participants With Early Onset SCN2A Developmental and Epileptic Encephalopathy
NCT05737784 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Extension Study to Evaluate NBI-827104 in Pediatric Participants With Epileptic Encephalopathy With Continuous Spike-and-Wave During Sleep
NCT05301894 ·Status: TERMINATED ·Phase: PHASE2
-
A Clinical Trial of PRAX-562 in Subjects With Developmental and Epileptic Encephalopathies (DEE)
NCT05818553 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Preventing Epilepsy Using Vigabatrin In Infants With Tuberous Sclerosis Complex
NCT02849457 ·Status: COMPLETED ·Phase: PHASE2
-
A Cohort Study on the Prognosis of Neonatal KCNQ2 Gene-associated Epileptic Encephalopathy
NCT03934268 ·Status: UNKNOWN
-
A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)
NCT06660394 ·Status: RECRUITING ·Phase: PHASE3
-
A Natural History Study of Participants With Potassium Sodium-Activated Channel Subfamily T Member 1 (KCNT1)-Related Epilepsy
NCT04924153 ·Status: COMPLETED
-
Phenylbutyrate for Monogenetic Developmental and Epileptic Encephalopathy
NCT04937062 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
A Study of the Effects of JNJ-26489112 on the Photic Induced Paroxysmal Electroencephalogram (EEG) Response in Patients With Photosensitive Epilepsy
NCT00579384 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Antiepileptic Drug Effects on Child Development
NCT00353886 ·Status: COMPLETED
-
CNKSR2 Natural History Study
NCT06500260 ·Status: RECRUITING
-
LEONIDaS Caregivers Study
NCT05140122 ·Status: WITHDRAWN
-
Fenfluramine for Adult Dravet Patients
NCT05560282 ·Status: TERMINATED ·Phase: PHASE3
-
Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study
NCT00088452 ·Status: COMPLETED ·Phase: PHASE3